<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>What It Takes to Build an FDA-Approved Oncology Plant in India</title>
    <link>https://www.taxtmi.com/news?id=52246</link>
    <description>Establishing an oncology manufacturing facility in India demands adherence to Good Manufacturing Practice and international regulatory standards, including full containment, validated cleanroom and HVAC zoning, WFI systems, and continuous environmental monitoring. Comprehensive validation through IQ, OQ, and PQ across processes and equipment is required, alongside parallel licensing steps-site selection, state manufacture licence, CDSCO approval, and US FDA registration. Thorough documentation, deviation closure, staff training, data integrity measures, and inspection readiness are essential to avoid Form 483 findings and secure access to regulated global markets.</description>
    <language>en-us</language>
    <pubDate>Tue, 12 Aug 2025 12:01:04 +0530</pubDate>
    <lastBuildDate>Tue, 12 Aug 2025 12:01:04 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=842536" rel="self" type="application/rss+xml"/>
    <item>
      <title>What It Takes to Build an FDA-Approved Oncology Plant in India</title>
      <link>https://www.taxtmi.com/news?id=52246</link>
      <description>Establishing an oncology manufacturing facility in India demands adherence to Good Manufacturing Practice and international regulatory standards, including full containment, validated cleanroom and HVAC zoning, WFI systems, and continuous environmental monitoring. Comprehensive validation through IQ, OQ, and PQ across processes and equipment is required, alongside parallel licensing steps-site selection, state manufacture licence, CDSCO approval, and US FDA registration. Thorough documentation, deviation closure, staff training, data integrity measures, and inspection readiness are essential to avoid Form 483 findings and secure access to regulated global markets.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Tue, 12 Aug 2025 12:01:04 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=52246</guid>
    </item>
  </channel>
</rss>